Cochrane Review Group

Tobacco Addiction

68 systematic reviews in Tobacco Addiction ask 430 questions. 6% have no studies to answer them, 27% rest on very low certainty evidence and 27.2% reach moderate or high certainty.

Reviews

Questions

430

current versions

No studies

Moderate or high

27.2%

No studies 26 · 6%Ungraded 12 · 2.8%Very low 116 · 27%Low 159 · 37%Moderate 87 · 20.2%High 30 · 7%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Search questions in Tobacco Addiction

Thinnest evidence

All no studies and very low questions

Question	Effect	Evidence	Status / GRADE
Smoking cessation counselling vs no smoking cessation counselling, grouped by intensity of intervention Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care Interventions for smoking cessation in hospitalised patients (2024) · Cochrane	RR 1.52 [0.8, 2.89]	2 studies · 1417 participants	Very low
Telephone quitline referral vs no treatment or usual care Quitline referral vs control · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane	RR 1.17 [0.7, 1.96]	2 studies · 1870 participants	Very low
Telephone quitline referral vs no treatment or usual care Health system telephone counselling vs quitline · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane	RR 1.23 [1, 1.51]	3 studies · 3260 participants	Very low
Smoking cessation counselling vs no smoking cessation counselling, grouped by intensity of intervention Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care Interventions for smoking cessation in hospitalised patients (2024) · Cochrane	RR 1.04 [0.9, 1.2]	7 studies · 4627 participants	Very low
Hospital‐only intervention vs intervention that continues after hospital discharge Behavioural support ‐ asynchronous** · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane	RR 0.97 [0.83, 1.14]	2 studies · 1598 participants	Very low
Nicotine EC vs behavioural support only/no support Serious adverse events at 4 weeks to 8 months Assessed via self‐report and medical records · People who smoke Electronic cigarettes for smoking cessation (2024) · Cochrane	RR 0.89 [0.59, 1.34]	10 studies · 3263 participants	Very low
Intervention NR Bupropion therapy plus behavioral intervention vs behavioral intervention alone (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane	RR 0.77 [0.42, 1.41]	121 participants	Very low
Intervention NR Bupropion therapy plus behavioral support versus self‐help (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane	RR 1.94 [0.94, 4]	86 participants	Very low
Intervention NR E‐health interventions · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane	OR 1.48	2 studies · 389 participants	Very low
Cytisine vs varenicline Neuropsychiatric SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane	no estimate extracted	NR	No studies
Cytisine vs varenicline Cardiac SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane	no estimate extracted	NR	No studies
Cytisine vs nicotine replacement therapy SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane	RR 1.15 [0.76, 1.75]	1 study · 1310 participants	Very low

Reviews 68

Interventions to reduce harm from continued tobacco use

Lindson‐Hawley, N, Hartmann‐Boyce, J, et al. · Cochrane Database of Systematic Reviews · 2016

Tobacco Addiction

Thinnest evidence

Reviews 68

Interventions to reduce harm from continued tobacco use

Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption

Combined pharmacotherapy and behavioural interventions for smoking cessation

Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders

Interventions for tobacco use cessation in people living with HIV and AIDS

Impact of institutional smoking bans on reducing harms and secondhand smoke exposure

Family‐based programmes for preventing smoking by children and adolescents

Immunotherapy (oral and sublingual) for food allergy to fruits

Acupuncture and related interventions for smoking cessation

Interventions for preoperative smoking cessation

Workplace interventions for smoking cessation

Use of electronic health records to support smoking cessation

School policies for preventing smoking among young people

Smoking cessation interventions for smokers with current or past depression

Training health professionals in smoking cessation

Interventions for smoking cessation in Indigenous populations

Oral immunotherapy for milk allergy

Community interventions for preventing smoking in young people